Oct 20, 2026 06:00AM
Oct 20, 2026 06:00AM
Aug 24, 2026 07:00AM
Aug 5, 2026 07:00AM
May 7, 2026 07:00AM
Apr 21, 2026 04:30PM
Apr 21, 2026 04:30PM Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting
Mar 16, 2026 09:07AM
Mar 10, 2026 07:00AM
Mar 9, 2026 07:00AM
Mar 9, 2026 07:00AM
Jan 7, 2026 07:00AM
Jan 7, 2026 07:00AM
Dec 19, 2025 05:19AM Goldman Sachs Reiterates Buy Rating on Rapport Therapeutics (RAPP)
Dec 5, 2025 09:01AM
Dec 5, 2025 09:00AM
Nov 25, 2025 07:00AM
Nov 25, 2025 07:00AM
Nov 6, 2025 07:00AM
Sep 9, 2025 06:45AM
Sep 8, 2025 06:00AM Rapport's epilepsy drug meets key goals in phase 2a trial
Sep 8, 2025 06:00AM
Aug 7, 2025 07:00AM
Jun 2, 2025 02:45PM
May 8, 2025 07:00AM
Mar 21, 2025 07:00AM
Mar 11, 2025 07:00AM
Mar 3, 2025 07:02AM Rapport Therapeutics (RAPP) Appoints Jeffrey Sevigny as Chief Medical Officer
Mar 3, 2025 07:00AM
Jan 9, 2025 09:12AM
Jan 9, 2025 09:12AM
Jan 9, 2025 07:00AM
Jan 9, 2025 07:00AM
Jan 6, 2025 10:35AM
Dec 6, 2024 12:01PM Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures
Nov 14, 2024 07:00AM
Nov 7, 2024 07:00AM
Aug 8, 2024 07:00AM
Jul 29, 2024 07:00AM

335,202 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All